pyrazines has been researched along with Hibernation, Myocardial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, A; Cohen, S; Jacobsen, J; Romero-Perez, D; Thomas, R; Villarreal, F; Yan, Y | 1 |
| Dutka, DP; Heck, PM; Hoole, SP; Khan, FZ; Read, PA | 1 |
2 other study(ies) available for pyrazines and Hibernation, Myocardial
| Article | Year |
|---|---|
Effects of novel semiselective matrix metalloproteinase inhibitors on ex vivo cardiac structure-function.
Topics: Animals; Coronary Circulation; Hydroxamic Acids; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Myocardial Contraction; Myocardial Stunning; Oligopeptides; Pyrazines; Pyridones; Pyrones; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sulfonamides | 2009 |
DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease.
Topics: Coronary Artery Disease; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography, Stress; Female; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Myocardial Stunning; Pilot Projects; Pyrazines; Reproducibility of Results; Sitagliptin Phosphate; Triazoles; Ventricular Dysfunction, Left | 2010 |